Key PointsIt comes as no surprise that artificial intelligence plays a key role in most of these performances.

The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going

Key PointsAI stocks have been known for explosive gains in recent years and have driven the S&P 500 higher.

Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?

Key PointsModerna is leveraging its mRNA platform to expand beyond COVID-19 vaccines into RSV and oncology therapeutics.

Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsModerna's market cap has soared on positive results for its mRNA cancer vaccine.

Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?

(RTTNews) - The following biotech stocks reached a 52-week high on October 9, 2026, driven by catalysts such as achieving new regulatory milestones.

Biotech Stocks At 52-Week Highs - HUM +11%, MRNA +14%, PBYI, ABBV, RCEL 

Key PointsModerna's stock has skyrocketed on exciting results from its personalized cancer vaccine.

These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna, Inc. News